Phlow and OrbitalRX Improve Pharmaceutical Supply Chain Management within Hospital Pharmacies Through Strategic Partnership
Phlow, a South Carolina-based medicine supply chain company, reeled in $36 million in series B fundraising to help the company expand its contract manufacturing program.
The U.S. Department of Justice and the Securities and Exchange Commission (SEC) have charged former Phlow Vice President Andrew Stiles with insider training, alleging that he and his cousin, Gray Stiles, netted more than $1.5 million on purchases of stock made using nonpublic information about a government pandemic preparedness contract awarded to Eastman Kodak.
Phlow, a Virginia-based CDMO, has teamed with the nonprofit U.S. Pharmacopeia (USP) to open a new drug development lab to focus on research and development of new drugs and advanced manufacturing technologies.
On December 12th, 2022, Phlow Corp. will expand its CDMO services and open its new laboratory co-located in Richmond, VA at the Advanced Pharmaceutical Development Center alongside its industry-leading partner, United States Pharmacopeia (USP).
According to a Form D filing from the SEC, Phlow Corp., a manufacturer that prides itself on making materials in the US instead of relying on sources overseas, is looking to raise $50 million in a funding round.